Nvwm LLC Buys 1,204 Shares of Danaher Corporation $DHR

Nvwm LLC increased its position in Danaher Corporation (NYSE:DHR) by 20.4% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,093 shares of the conglomerate’s stock after purchasing an additional 1,204 shares during the period. Nvwm LLC’s holdings in Danaher were worth $1,401,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Red Tortoise LLC increased its position in shares of Danaher by 175.0% during the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after acquiring an additional 98 shares in the last quarter. Ramirez Asset Management Inc. purchased a new position in shares of Danaher in the second quarter worth $40,000. Costello Asset Management INC bought a new position in shares of Danaher during the first quarter valued at $41,000. Mowery & Schoenfeld Wealth Management LLC increased its holdings in Danaher by 53.8% in the 1st quarter. Mowery & Schoenfeld Wealth Management LLC now owns 203 shares of the conglomerate’s stock worth $42,000 after buying an additional 71 shares in the last quarter. Finally, Iron Horse Wealth Management LLC bought a new stake in Danaher in the 1st quarter worth about $50,000. 79.05% of the stock is currently owned by institutional investors.

Danaher Stock Performance

NYSE DHR opened at $210.97 on Friday. The business has a 50-day moving average price of $203.94 and a 200-day moving average price of $200.14. The firm has a market cap of $149.02 billion, a price-to-earnings ratio of 43.50, a price-to-earnings-growth ratio of 3.28 and a beta of 0.81. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $258.23. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share for the quarter, topping the consensus estimate of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The business had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. During the same period in the prior year, the company posted $1.71 EPS. The firm’s revenue for the quarter was up 4.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities research analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 31st. Shareholders of record on Friday, September 26th were paid a $0.32 dividend. The ex-dividend date of this dividend was Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher’s payout ratio is presently 26.39%.

Insiders Place Their Bets

In related news, Director Teri List sold 2,778 shares of the company’s stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director owned 20,751 shares of the company’s stock, valued at $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 11.10% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently issued reports on DHR shares. Rothschild & Co Redburn reaffirmed a “neutral” rating and set a $220.00 price target (down previously from $245.00) on shares of Danaher in a report on Wednesday, October 8th. JPMorgan Chase & Co. increased their target price on Danaher from $260.00 to $270.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. Wells Fargo & Company restated a “positive” rating on shares of Danaher in a research note on Thursday, October 23rd. Evercore ISI increased their price objective on shares of Danaher from $226.00 to $245.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 7th. Finally, Bank of America cut their target price on shares of Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a research report on Monday, September 22nd. Eighteen investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $243.39.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.